Behavioral Neurobiology of Psychedelic Drugs
Editors: Halberstadt, Adam, Vollenweider, Franz X., Nichols, David E. (Eds.)
Free Preview- The volume brings together clinical and preclinical research literatures
- A balanced view of the potential risks and benefits of these compounds is presented
- The focus is on rigorous scientific findings in a field that has been fraught with speculative reports
Buy this book
- About this book
-
This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline. Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action. Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level. To the extent possible, contributions relate the clinical and preclinical findings to one another across species. The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.
- Reviews
-
“This book brings together the latest basic and clinical research into the underlying mechanism of action, effects, and possible clinical uses of psychedelic drugs. … It brings together current knowledge regarding this class of drugs pharmacology, neurobiological effects, subjective experience, and therapeutic effects. … It brings together preclinical and clinical data, which will be of interest to anyone involved with or curious about this category of drugs.” (Michael Easton, Doody's Book Reviews, September, 2018)
- Table of contents (15 chapters)
-
-
Chemistry and Structure–Activity Relationships of Psychedelics
Pages 1-43
-
Erratum to: Phenomenology, Structure, and Dynamic of Psychedelic States
Pages 1-1
-
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
Pages 45-73
-
Effects of Hallucinogens on Neuronal Activity
Pages 75-105
-
Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons
Pages 107-135
-
Table of contents (15 chapters)
Recommended for you
Bibliographic Information
- Bibliographic Information
-
- Book Title
- Behavioral Neurobiology of Psychedelic Drugs
- Editors
-
- Adam Halberstadt
- Franz X. Vollenweider
- David E. Nichols
- Series Title
- Current Topics in Behavioral Neurosciences
- Series Volume
- 36
- Copyright
- 2018
- Publisher
- Springer-Verlag Berlin Heidelberg
- Copyright Holder
- Springer-Verlag GmbH Germany, part of Springer Nature
- eBook ISBN
- 978-3-662-55880-5
- DOI
- 10.1007/978-3-662-55880-5
- Hardcover ISBN
- 978-3-662-55878-2
- Softcover ISBN
- 978-3-662-58563-4
- Series ISSN
- 1866-3370
- Edition Number
- 1
- Number of Pages
- X, 430
- Number of Illustrations
- 38 b/w illustrations, 158 illustrations in colour
- Topics
*immediately available upon purchase as print book shipments may be delayed due to the COVID-19 crisis. ebook access is temporary and does not include ownership of the ebook. Only valid for books with an ebook version. Springer Reference Works and instructor copies are not included.
